Noesion Radarnoesion.ai
Market2026-07-30

Simile, a Palo Alto-based startup building simulations of human behavior, announced a Series B of over $200 million at a $2 billion post-money valuation, co-led by Greenoaks and Index Ventures with participation from Hanabi, Bain Capital Ventures, A*, Factory, CVS Health Ventures and Definition. The company says it launched five months earlier, grew revenue 5x, expanded to a global team of 50+, and built a foundation model for human behavior that has run tens of millions of simulations for Fortune 100 enterprises, plus a confidence model that predicts the accuracy of each simulation. Named customers include CVS Health, Wealthfront, Deloitte and Gallup, using the technology for product launches, customer experience and market entry decisions. Its stated mission is to simulate all eight billion people.

Send this to someone who needs it

Shares the story and its sources. Nothing about you.

What does this mean for your job?

This is the story as everyone gets it. Once a week we send you the version written for your role — what changed, why it matters for the work you actually do, and one thing to try. Free while we tune it.